A guide to biological skin substitutes

British Journal of Plastic Surgery

Volumn 55, Issue 3, 2002, Pages 185-193

  Jones, Isabel ^a   Currie, Lachlan ^a   Martin, Robin ^a  

^a QUEEN VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Burns; Skin replacements; Skin substitutes; Wounds

Indexed keywords

COLLAGEN; GLYCOSAMINOGLYCAN; HYALURONIC ACID; NYLON; POLYGLACTIN; POLYGLYCOLIC ACID; SILICONE;

ARTIFICIAL SKIN; BURN; CHRONIC DISEASE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FIBROBLAST; HEALTH PRACTITIONER; HUMAN; KERATINOCYTE; MEDICAL TECHNOLOGY; PRIORITY JOURNAL; REVIEW; SKIN SURGERY; WOUND;

EID: 0036268529     PISSN: 00071226     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjps.2002.3800     Document Type: Review

References (87)

1. Alternative wound coverings
2. Characteristics and uses of biologic dressings and skin substitutes
3. Current trends in the use of allograft skin for patients with burns and reflections on the future of skin banking in the United States
4. Effect of storage and preservation methods on viability in transplantable human skin allografts
5. Synthetic materials for covering burn wounds: Progress towards perfection. Longer term substitutes for skin
6. A new composite skin prosthesis
7. DRG-driven change in burn wound management: A success story
8. Biosynthetic skin substitute versus frozen human cadaver allograft for temporary coverage of excised burn wounds
9. Clinical trials of a biosynthetic temporary skin replacement, Dermagraft-transitional covering, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds
10. A multicenter clinical trial of a biosynthetic skin replacement, Dermagraft-TC, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds
11. A histologic study of Dermagraft-TC in patients' burn wounds
12. The use of a bioactive skin substitute decreases length of stay for pediatric burn patients
13. Dermagraft-TC for partial-thickness burns: A clinical evaluation
14. Enteral nutritional support and wound excision and closure do not prevent postburn hypermetabolism as measured by continuous metabolic monitoring
15. Management of partial thickness facial burns (comparison of topical antibiotics and bio-engineered skin substitutes)
16. Cultured human epidermal cells do not synthesize HLA-DR
17. Study of HLA-DR synthesis in cultured human keratinocytes
18. Cultured composite skin grafts: Biological skin equivalents permitting massive expansion
19. Survival of cultured allogeneic keratinocytes transplanted to deep dermal bed assessed with probe specific for Y chromosome
20. Cultured epidermal autografts and allografts: A study of differentiation and allograft survival
21. Long-term survival and immunological tolerance of human epidermal allografts produced in culture
22. Clinical observations and methods for identifying the existence of cultured epidermal allografts
23. Growth regulation of skin cells by epidermal cell-derived factors: Implications for wound healing
24. Progressive replacement of human cultured epithelial allografts by recipient cells as evidenced by HLA class I antigens expression
25. Cultured epidermal allografts as biological wound dressings
26. Survival of allogeneic cells in cultured organotypic skin grafts
27. Treatment of chronic venous ulcers with sheets of cultured allogenic keratinocytes
28. Multicentre experience in the treatment of burns with autologous and allogenic cultured epithelium, fresh or preserved in a frozen state
29. Allogeneic-syngeneic cultured epithelia: A successful therapeutic option for skin regeneration
30. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent
31. Cultured skin as a 'smart material' for healing wounds: Experience in venous ulcers
32. A composite skin substitute (graftskin) for surgical wounds. A clinical experience
33. Tissue engineering in wound repair
34. The effect of a tissue engineered bilayered living skin analog, over meshed split-thickness autografts on the healing of excised burn wounds
35. Evaluation of a biodegradable matrix containing cultured human fibroblasts as a dermal replacement beneath meshed skin grafts on athymic mice
36. Development of a temporary living skin replacement composed of human neonatal fibroblasts cultured in Biobrane, a synthetic dressing material
37. In vivo optimization of a living dermal substitute employing cultured human fibroblasts on a biodegradable polyglycolic acid or polyglactin mesh
38. A metabolically active human dermal replacement for the treatment of diabetic foot ulcers
39. Cost-effectiveness modeling of Dermagraft for the treatment of diabetic foot ulcers in the French context
40. Clinical trials of a living dermal tissue replacement placed beneath meshed, split-thickness skin grafts on excised burn wounds
41. Clinical evaluation of an acellular allograft dermal matrix in full-thickness burns
42. The use of a permanent dermal allograft in full-thickness burns of the hand and foot: A report of three cases
43. Design of an artificial skin. I. Basic design principlese
44. Design of an artificial skin. II. Control of chemical composition
45. Successful use of a physiologically acceptable artificial skin in the treatment of extensive burn injury
46. Artificial dermis for major burns: A multi-center randomized clinical trial
47. Artificial skin in massive burns - Results to ten years
48. Histologic study of artificial skin used in the treatment of full-thickness thermal injury
49. Vascularized collagen-glycosaminoglycan matrix provides a dermal substrate and improves take of cultured epithelial autografts
50. The use of cultured autologous keratinocytes with Integra in the resurfacing of acute burns
51. Enhancement of cell interactions with collagen/glycosaminoglycan matrices by RGD derivatization
52. A bilayer 'artificial skin' capable of sustained release of an antibiotic
53. Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin
54. Serial cultivation of strains of human epidermal keratinocytes: The formation of keratinizing colonies from single cells
55. Growth of cultured human epidermal cells into multiple epithelia suitable for grafting
56. Permanent coverage of large burn wounds with autologous cultured human epithelium
57. Cultured epithelial autografts in extensive burn coverage of severely traumatized patients: A five year single-center experience with 30 patients
58. Cultured epithelial autografts for giant congenital nevi
59. Treatment of junctional epidermolysis bullosa with epidermal autografts
60. Scalp necrosis in a neonate treated with cultured autologous keratinocytes
61. Acceleration of skin regeneration from cultured epithelial autografts by transplantation to homograft dermis
62. A porcine model using skin graft chambers for studies on cultured keratinocytes
63. An animal model to study the significance of dermis for grafting cultured keratinocytes on full thickness wounds
64. Wound bed preparation: Approaches to replacement of dermis
65. Addendum: Multicenter experience with cultured epidermal autograft for treatment of burns
66. Cultured epidermis: Indiana University Medical Center's experience
67. Treatment of skin defects using suspensions of in vitro cultured keratinocytes
68. Burn wounds resurfaced by cultured epidermal autografts show abnormal reconstitution of anchoring fibrils
69. Skin regenerated from cultured epithelial autografts on full-thickness burn wounds from 6 days to 5 years after grafting. A light, electron microscopic and immunohistochemical study
70. Histological evaluation of human cultured epithelium before and after grafting
71. Retroviral marking identifies grafted autologous keratinocytes in porcine wounds receiving cultured epithelium
72. Keratinocyte grafting: A new means of transplantation for full-thickness wounds
73. Cultured autologous keratinocytes in fibrin glue suspension, exclusively and combined with STS-allograft (preliminary clinical and histological report of a new technique)
74. Use of human keratinocytes cultured on fibrin glue in the treatment of burn wounds
75. Long-term regeneration of human epidermis on third degree burns transplanted with autologous cultured epithelium grown on a fibrin matrix
76. The coapplication of sprayed cultured autologous keratinocytes and autologous fibrin sealant in a porcine wound model
77. Development and evaluation of a new composite Laserskin graft
78. A new model of epidermal culture for the surgical treatment of vitiligo
79. A new technique to resurface wounds with composite biocompatible epidermal graft and artificial skin
80. Sprayed keratinocyte suspensions accelerate epidermal coverage in a porcine microwound model
81. Epithelial-mesenchymal interactions enhance expression of collagen VII in vitro
82. A comparison of methodologies for the preparation of human epidermal-dermal composites
83. Development of autologous human dermal-epidermal composites based on sterilized human allodermis for clinical use
84. Biologic attachment, growth, and differentiation of cultured human epidermal keratinocytes on a graftable collagen and chondroitin-6-sulfate substrate
85. Burn wound closure with cultured autologous keratinocytes and fibroblasts attached to a collagen-glycosaminoglycan substrate
86. Skin substitutes from cultured cells and collagen-GAG polymers
87. The 1999 clinical research award. Cultured skin substitutes combined with Integra artificial skin to replace native skin autograft and allograft for the closure of excised full-thickness burns